Urology Journal Articles

• 11.00 91.00
  Telepharmacy and Quality of Medication Use in Rural Areas, 2013–2019
  Preventing Chronic Disease September 03, 2020
  A new study compares telepharmacies with traditional pharmacies.
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
  Morbidity & Mortality Weekly Report July 14, 2020
  CDC recommends HCV screening at least once in a lifetime for all adults and all pregnant women during each pregnancy except low-prevalence.
  
  
  Save
• Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices —United States, 2018-2019 Influenza Season
  Morbidity & Mortality Weekly Report October 31, 2018
  The Advisory Committee on Immunization Practices updated their 2017-2018 recommendations regarding use of seasonal influenza vaccines in the United States, including use of live attenuated influenza vaccine quadrivalent.
  
  
  Save
• Patterns and Trends in Cancer Screening in the United States: Results from the 2000-2015 National Health Interview Surveys
  Preventing Chronic Disease July 26, 2018
  Cervical, breast, and colorectal cancer screening remains below Healthy People 2020 targets, based on 2015 NHIS findings, particularly for patients with no usual source of care or insurance and those who are non-Hispanic Asian.
  
  
  Save
• Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017
  Morbidity & Mortality Weekly Report June 27, 2018
  Better detection and aggressive early response to emerging antibiotic resistance may slow further spread, as seen with carbapenem-resistant Enterobacteriaceae infections vs the extended-spectrum β-lactamase phenotype.
  
  
  Save
• Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase–Producing Escherichia coli Infections in Patients with Pyelonephritis, United States
  Emerging Infectious Diseases August 12, 2016
  Fluoroquinolone resistance and extended-spectrum β-lactamase production are disturbingly common in cases of pyelonephritis in the United States.
  
  
  Save
• How Do You Know Which Health Care Effectiveness Research You Can Trust? A Guide to Study Design for the Perplexed
  Preventing Chronic Disease June 25, 2015
  This report details the practical application of the medical literature: how to spot questionable research.
  
  
  Save
• Urinary Incontinence in the Young Woman; Treatment Plans and Options Available
  Women's Health March 01, 2014
  Urinary incontinence is relatively common among young women. The current review provides an evidence-based guide to the diagnosis and management of urinary incontinence among women of childbearing age.
  
  Save
• Patient Goals in Urogynecology
  Expert Review of Obstetrics & Gynecology July 01, 2012
  The use of patient-centered goals in the treatment of urogynecologic conditions has emerged as an important means to direct therapy. The current review highlights how to use this paradigm to achieve superior patient outcomes.
  
  Save
• Genitourinary Tuberculosis: Etiology and Management
  Nature Reviews Urology December 01, 2011
  Genitourinary tuberculosis is a diagnosis commonly missed by the treating physician. The current review will help clinicians to better identify and manage genitourinary tuberculosis.
  
  Save
• Urothelial Carcinoma of the Bladder: Definition, Treatment, and Future Efforts
  Nature Reviews Urology November 01, 2011
  Urothelial Carcinoma of the Bladder lesions are often understaged at the time of surgery and vigilance is needed to accurately assess staging to select the most appropriate treatment.
  
  Save
• Selecting Targeted Therapies for Patients With Renal Cell Carcinoma
  JNCCN - Journal of the National Comprehensive Cancer Network September 01, 2011
  Treatment choice for advanced RCC can be guided by the disease setting, histology, and patient characteristics, comorbidities, and preference, on the basis of available evidence.
  
  Save
• Prevention and Management of TURP-Related Hemorrhage
  Nature Reviews Urology September 01, 2011
  What are the best means to reduce the risk for bleeding associated with TURP? The current review focuses on evidence-based answers to this question.
  
  Save
• Prognostic Factors for Upper Urinary Tract Urothelial Carcinoma
  Nature Reviews Urology July 05, 2011
  Upper urinary tract urothelial carcinoma is a rare tumor, yet there have been advances in research. The current review describes the research, and offers insight into new directions for study.
  
  Save
• Radiation Therapy for Prostate Cancer After Prostatectomy: Adjuvant or Salvage?
  Nature Reviews Urology July 01, 2011
  What is the best timing for radiation therapy among men who received prostatectomy for prostate cancer? The current review investigates this issue.
  
  Save
• Misdiagnosis of Clear Cell Renal Cell Carcinoma
  Nature Reviews Urology June 01, 2011
  Clear cell renal cell carcinoma may be misdiagnosed based on clinical and radiologic findings alone. This review provides insight to increase physicians' accuracy in diagnosing clear cell renal cell carcinoma.
  
  Save
• Management of Renal Cell Carcinoma: What Can Molecular Pathology Contribute?
  Nature Reviews Urology May 01, 2011
  Can molecular pathology help guide treatment decisions for patients with renal cell carcinoma? The current review addresses this issue.
  
  Save
• Testicular Descent: Testosterone and the Intrauterine Milieu
  Nature Reviews Urology April 01, 2011
  What do we understand regarding the pathophysiology of cryptorchidism? The current study addresses this issue.
  
  Save
• Testicular Microlithiasis: Understanding and Management
  Nature Reviews Urology March 01, 2011
  What is the significance of testicular microlithiasis? The current review answers this question and provides recommendations for the management of men with testicular microlithiasis.
  
  Save
• Low-Risk Bladder Cancer: Contemporary Management
  Nature Reviews Urology January 01, 2011
  What can physicians do to reduce the risk for recurrence of low-risk bladder cancer? The current review highlights the best practice for these tumors.
  
  Save